After eating, the body breaks down carbohydrates into glucose, which is absorbed into the bloodstream. This causes a rise in blood sugar levels. For...
Vous n'êtes pas connecté
Researchers from Thomas Jefferson University have found that a combination of two diabetes drugs, dapagliflozin and exenatide, continues to effectively manage blood sugar levels in people with Type 2 diabetes, even after two years of continuous use. This discovery offers hope for patients who struggle to keep their blood glucose levels under control over the […]
After eating, the body breaks down carbohydrates into glucose, which is absorbed into the bloodstream. This causes a rise in blood sugar levels. For...
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a newer class of drugs used to manage diabetes, have recently been linked to a rare but serious...
Maxwell Ademeyi DIABETES can manifest in various ways, especially at night. It is crucial to recognise these night-time signs to prevent further...
Diabetes affects over 37 million people in the U.S., with many of them living with type 2 diabetes. This form of diabetes used to be most common among...
Diabetes affects over 37 million people in the U.S., with many of them living with type 2 diabetes. This form of diabetes used to be most common among...
FRIDAY, Sept. 13, 2024 -- Initially approved to treat type 2 diabetes, Ozempic and Mounjaro also can help people with type 1 diabetes lose weight and...
FRIDAY, Sept. 13, 2024 -- Initially approved to treat type 2 diabetes, Ozempic and Mounjaro also can help people with type 1 diabetes lose weight and...
Our glycemic balance is based on the ability of the pancreatic beta cells to detect glucose and secrete insulin to maintain our blood sugar levels. If...
WEDNESDAY, Sept. 4, 2024 -- A sweat-powered finger wrap could make monitoring a person’s health as easy as wearing a Band-Aid, researchers...
When not addressed, the prolonged chronic high blood sugar levels may lead to damaged body systems. This damage is particularly problematic for the...